AIFM2 and lung carcinoma: In lung cancer, several proteins have been identified to modulate the ferroptosis process and influence tumor fates, among which GPX4 and FSP1 can reduce the sensitivity of lung cancer to ferroptosis by enhancing cellular antioxidant capacity.